Amr Morsy
Vermögen: 4 Mio $ am 30.06.2026
Vermögen: 4 Mio $ am 30.06.2026
Dr. Amr Morsy is a Chief Executive Officer & Executive Director at Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda.
He is on the Board of Directors at Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda.
Dr. Morsy was previously employed as a Country Manager by Pfizer Egypt.
He received his undergraduate degree from Alexandria University and an MBA from the Arab Academy for Science, Technology & Maritime Transport.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 44’344’635 ( 2.22% ) | 4 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) (S.A.E) | Vorstandsvorsitzender | 01.01.2011 |
| Unternehmen | Position | Ende |
|---|---|---|
Pfizer Egypt
Pfizer Egypt Pharmaceuticals: MajorHealth Technology Produces and distributes pharmaceuticals and medicines | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Pfizer Egypt
Pfizer Egypt Pharmaceuticals: MajorHealth Technology Produces and distributes pharmaceuticals and medicines | Health Technology |
Alexandria University
Alexandria University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arab Academy for Science, Technology & Maritime Transport
Arab Academy for Science, Technology & Maritime Transport Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda Pharmaceuticals: MajorHealth Technology Manufactures and markets generic pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen